Estudios originales

Post-COVID symptoms prevalence, latent class pattern, and functional impact: A population-based cross-sectional study in two Chilean cities, 2024

Back to article
Population sociodemographic and clinical characteristics stratified by post-COVID-19 symptom classes resulting from LCA and bivariate comparisons across class, Chile, May 2024.
VariableCategoriesTotalClass 1Class 2Class 3p value b
N%%%%
Total12552210038.4 (24.4 to 54.7)40.7 (24.3 to 59.5)20.9 (6.7 to 49.0)
SexMale5677945.240.3 (24.8 to 57.9)40.7 (15.8 to 71.5)63.2 (17.2 to 93.4)0.61
Female6874354.859.7 (42.1 to 75.2)59.3 (28.5 to 84.2)36.8 (6.6 to 82.8)
Age group< 30 years2847322.715.0 (6.1 to 32.2)32.8 (9.2 to 70.2)17.1 (1.7 to 70.5)0.40
30 to 59 years8550568.170.9 (54.6 to 83.1)58.0 (28.2 to 82.9)82.8 (29.6 to 98.2)
60 years and over115449.214.1 (6.7 to 27.3)9.2 (3.7 to 21.3)0.1 (0.006 to 0.9)
Aboriginal affiliationYes3465227.614.0 (8.3 to 22.5)13.9 (4.9 to 33.5)79.4 (41.2 to 95.5)0.00
No9087072.486.0 (77.5 to 91)86.1 66.5 to 95.1)20.6 (4.5 to 58.8)
Education (age 18 years or more)High school or less6346751.656.4 (37.9 to 73.3)65.2 (42.0 to 82.9)17.0 (3.8 to 51.3)0.00
Higher Technician3928731.928.6 (13.4 to 50.8)11.3 (6.0 to 20.4)76.9 (36.9 to 95.0)
Professional/postgraduate2032416.515.0 (8.7 to 24.5)23.5 (10.8 to 43.7)6.1 (0.6 to 41.1)
InsurancePublic11303791.092.2 (83.7 to 96.4)88.6 (74.2 to 95.5)93.4 (58.7 to 99.3)0.89
Private102748.37.2 (3.1 to 15.6)10.2 (3.9 to 24.1)6.6 (0.7 to 41.2)
Armed forces9150.70.6 (0.08 to 4.6)1.2 (0.1 to 8.8)0.0
Body mass indexEmaciated7370.61.5 (0.3 to 8.3)0.00.00.08
Normal3795430.418.3 (9.5 to 32.4)54.1 (29.2 to 77.1)6.9 (0.8 to 40.2)
Overweight4012832.146.9 (29.5 to 65.0)23.2 (10.8 to 42.9)22.2 (3.1 to 71.4)
Obese4607036.933.3 (21.2 to 48.0)22.7 (10.6 to 41.9)70.9 (23.3 to 95.1)
TobaccoYes4405835.129.2 (14.1 to 50.8)21.4 (10.6 to 38.5)72.7 (25.1 to 95.5)0.08
No8146464.970.8 (49.1 to 85.9)78.6 (61.5 to 89.3)27.3 (4.5 to 74.9)
ComorbiditiesYes8614868.653.8 (36.8 to 70-0)70.3 (47.9 to 85.9)92.6 (66.8 to 98.7)0.03
No3937431.446.2 (30.0 to 63.2)29.7 (14.0 to 52.1)7.4 (1.3 to 33.1)
Neoplastic diseaseYes7020.60.00.9 (0.5 to 1.5)0.9 (0.1 to 8.1)0.34
No12482099.4100.099.1 (98.5 to 99.5)99.1 (91.8 to 99.9)
Heart diseaseYes59774.85.7 (0.8 to 31.3)4.6 (1.1 to 17.1)3.3 (0.3 to 26.8)0.93
No11954595.294.3 (68.6 to 99.2)95.4 (82.8 to 98.9)96.7 (73.2 to 99.7)
Chronic respiratory diseaseYes3005623.99.9 (3.2 to 26.4)37.6 (13.0 to 70.8)23.3 (3.3 to 72.9)0.28
No9546676.190.1 (73.6 to 96.8)62.4 (29.2 to 87.0)76.7 (27.1 to 96.7)
Chronic kidney diseaseYes22401.81.9 (0.2 to 12.9)0.9 (0.2 to 4.3)3.3 (0.3 to 26.8)0.64
No12328298.298.1 (87.1 to 99.7)99.1 (95.6 to 99.8)96.7 (73.2 to 99.7)
DiabetesYes2605920.84.6 (1.3 to 14.8)16.4 (8.1 to 30.2)59.0 (13.9 to 92.8)0.01
No9946379.295.4 (85.2 to 98.7)83.6 (69.8 to 91.8)41.0 (72.0 to 86.1)
HypertensionYes2201417.525.6 (10.7 to 49.6)14.0 (5.7 to 30.5)9.6 (2.1 to 34.1)0.34
No10350882.574.4 (50.4 to 89.3)86.0 (69.5 to 94.3)90.4 (65.9 to 97.9)
Self-reported obesityYes116189.314.6 (6.8 to 28.3)4.3 (1.6 to 10.6)9.2 (1.6 to 38.0)0.25
No11390490.785.4 (71.6 to 93.2)95.7 (89.3 to 98.3)90.8 62.0 to 98.3)
Autoimmune diseaseYes19081.51.7 (0.2 to 12.1)2.1 (0.3 to14.5)0.00.79
No12361498.598.3 (87.9 to 99.8)97.9 (85.5 to 99.7)100.0
VaccinationNo vaccine23561.90.02.6 (0.3 to 17.6)3.9 (0.3 to 30.1)0.32
First doce+ booster7090056.551.7 (33.9 to 69.1)72.0 (52.1 to 85.9)34.9 (6.1 to 81.3)
Bivalent or Omicron5226641.648.3 (30.9 to 66.0)25.3 (12.8 to 44.0)61.2 (15.5 to 93.1)
N° COVID episodes18135764.870.4 (48.5 to 85.7)80.0 (61.2 to 91.0)24.8 (3.9 to 73.0)0.04
2 or more4416535.229.6 (14.3 to 51.5)20.0 (9.0 to 38.8)75.2 (27.0 to 96.1)
HospitalizationYes1951715.56.0 (1.4 to 22.0)2.4 (0.4 to 13.5)58.9 (13.8 to 92.8)0.00
No10600584.594.0 (78.0 to 98.6)97.6 (86.4 to 99.6)41.1 (7.2 to 86.2)
Presence of symptomsFatigue or tiredness8373966.742.7 (25.3 to 62.0)73.1 (54.1 to 86.2)98.7 (87.4 to 99.9)0.00
Concentration difficulties3100924.711.0 (4.0 to 26.8)098.1 (83.1 to 99.8)0.00
Memory loss2783422.24.7 (1.4 to 14.1)097.7 (83.8 to 99.7)0.00
Ageusia/anosmia2324718.539.5 (24.7 to 56.4)1.4 (0.3 to 6.3)13.4 (2.5 to 48.2)0.00
Dyspnea7458359.40.0 -95.8 (89.3 to 98.4)97.8 (87.3 to 99.6)0.00
Chest pain3312426.410.2 (7.0 to 14.7)16.0 (6.2 to 35.1)76.5 (27.5 to 96.5)0.00
Palpitations2967923.64.7 (1.3 to 16.1)4.6 (1.4 to 14.4)95.7 (70.7 to 99.5)0.00
Dizziness1286710.27.7 (2.9 to 19.0)1.0 (0.2 to 4.7)33.0 (5.8 to 79.6)0.01
Menstrual change a734410.74.2 (0.9 to 18.0)1.0 (0.1 to 7.1)60.5 (19.0 to 90.9)0.00
Inability to exercise3535928.20.032.4 (8.9 to 70.0)71.9 (24.5 to 95.3)0.01
Joint and muscle pain4474935.629.5 (13.6 to 52.5)11.6 (4.6 to 26.4)93.9 (58.9 to 99.4)0.00
Reduction in daily activitiesYes, a little3909232.414.2 (5.7 to 31.2)54.6 (27.3 to 79.2)26.5 (4.3 to 74.3)0.14
Yes, a lot92907.73.8 (0.8 to 15.9)7.9 (19.5 to 27.1)14.5 (3.0 to 48.6)

aOnly women.

bChi2, two sided.

Source: Prepared by the authors of this study.